Abstract: A characterization device, system, and method for characterizing reflective elements from the light beams reflected in it. The device has two variable-gain detectors on a common structure, which can be portable or fixed, and for capturing light beams reflected by a reflective element, and from at least one processor characterizing the quality of the reflected light beams and evaluating the quality of the reflective element from its reflective capacity. Each detector has a lens for increasing the signal-to-noise ratio of the reflected beam or beams, a light sensor on which the beam or beams captured by the lens are focused, an automatic gain selection system associated with the optical sensor, and a data communication device associated with the device itself. A characterization system and a characterization method for characterizing reflective elements from the quality of the light beams reflected in at least one reflective element or heliostat.

Abstract: Thermoplastic compounds in the form of a pellet include thermoplastic resin and conductive fibers. The conductive fibers are enveloped by the thermoplastic resin and distributed within the pellet such that each of at least a portion of the conductive fibers is substantially surrounded by the thermoplastic resin and thereby substantially separated from physical contact with any other of the conductive fibers. Additionally, at least a portion of the conductive fibers includes long fibers. The thermoplastic compound, when molded at a thickness of about 3.2 mm, has an electromagnetic shielding effectiveness across a range of frequencies from about 0.5 GHz to about 2.0 GHz of at least about 60 dB according to ASTM D4935, which makes the thermoplastic compound useful for molding thermoplastic articles for shielding against electromagnetic interference.

Abstract: Chimeric antigen comprising multimeric aggregates of the extracellular domain of the programmed death ligand 1 (PD-L1) with a reduced binding capacity to the PD-1 and CD80 receptors as compared to the native PD-L1 molecule. The invention further discloses pharmaceutical compositions including said chimeric antigen and at least a pharmaceutically acceptable vaccine adjuvant. The chimeric antigen is used for the manufacturing of a drug to treat cancer or its metastases. The invention also discloses a method of treating cancer or its metastases in a subject in need thereof, characterized by the administration of a therapeutically effective amount of the pharmaceutical composition comprising the chimeric antigen described herein.

Abstract: Systems and methods for fine adjustment of computerized roof models are provided. The system generates a 3D roof structure model based on at least one image obtained from an aerial imagery database. Alternatively, the system could retrieve at least one stored 3D roof structure model from a 3D roof structure model database. The system weighs (e.g., scores) each 3D roof structure model candidate and determines an optimal 3D roof structure model by applying a variable neighborhood search to a 3D roof structure model candidate having a highest confidence score among the weighed 3D roof structure model candidates.

Abstract: There is provided a method for decreasing leakage of matter from an object to a surrounding, said object being coated with a coating at least partially applied on the object, said coating comprising an at least partially covering layer comprising silver, said object optionally comprising area(s) without said layer, said coating comprising metal particles applied on the layer and optionally on areas without said layer, said metal particles comprising palladium and at least one metal selected from the group consisting of gold, ruthenium, rhodium, osmium, iridium, niobium, neodymium and platinum and wherein the amount of the metal particles is in the interval 0.01-8 ?g/cm2. Advantages include that leakage of matter such as latex allergens of metal ions can be reduced while the coating is both biocompatible and antimicrobial. Further, the blood clotting can be reduced.

Abstract: A hardware implementation of a configurable pooling processing unit is configured to receive an input tensor comprising at least one channel, each channel of the at least one channel comprising a plurality of tensels; receive control information identifying one operation of a plurality of selectable operations to be performed on the input tensor, the plurality of selectable operations comprising a depth-wise convolution operation and one or more pooling operations; perform the identified operation on the input tensor to generate an output tensor by performing one or more operations on blocks of tensels of each channel of the at least one channel of the input tensor; and output the output tensor.

Abstract: A neural network accelerator includes a plurality of hardware processing units, each hardware processing unit comprising hardware to accelerate performing one or more neural network operations on data; and a crossbar coupled to each hardware processing unit of the plurality of hardware processing units and configured to selectively form, from a plurality of selectable pipelines, a pipeline from one or more of the hardware processing units of the plurality of hardware processing units to process input data to the neural network accelerator. The plurality of hardware processing units comprising (i) a convolution processing unit configured to accelerate performing convolution operations on data, and (ii) a configurable pooling processing unit configured to selectively perform an operation of a plurality of selectable operations on data, the plurality of selectable operations comprising a depth-wise convolution operation and one or more pooling operations.

Abstract: The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Cav1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

Abstract: A neural network accelerator that has a configurable hardware pipeline includes a plurality of hardware processing units, each hardware processing unit comprising hardware to accelerate performing one or more neural network operations on a tensor of data; and a crossbar coupled to each hardware processing unit of the plurality of hardware processing units, the crossbar configured to selectively form, from a plurality of selectable pipelines, a pipeline from one or more of the hardware processing units of the plurality of hardware processing units to process input data to the neural network accelerator. At least one of the hardware processing units is configurable to transmit or receive a tensor via the crossbar in a selected processing order of a plurality of selectable processing orders, and the selected processing order is based on the pipeline formed by the crossbar.

Abstract: Methods and devices for configuring a neural network accelerator that comprises a configurable hardware pipeline. The neural network accelerator includes a plurality of hardware processing units and a crossbar coupled to each hardware processing unit of the plurality of hardware processing units. Each hardware processing unit comprises hardware to accelerate performing one or more neural network operations on received data.

Abstract: A neural network accelerator that has a configurable hardware pipeline includes a plurality of hardware processing units and a crossbar configured to selectively form, from a plurality of selectable pipelines, a pipeline from one or more of the hardware processing units to process input data to the neural network accelerator. Each hardware processing unit comprises hardware to accelerate performing one or more neural network operations on data, and the plurality of hardware processing units comprises a convolution processing unit configured to accelerate performing convolution operations on data.

Abstract: Systems and methods for fine adjustment of computerized roof models are provided. The system generates a 3D roof structure model based on at least one image obtained from an aerial imagery database. Alternatively, the system could retrieve at least one stored 3D roof structure model from a 3D roof structure model database. The system weighs (e.g., scores) each 3D roof structure model candidate and determines an optimal 3D roof structure model by applying a variable neighborhood search to a 3D roof structure model candidate having a highest confidence score among the weighed 3D roof structure model candidates.

Abstract: Certain embodiments describe antiviral compounds and related methods of using such compounds.

Abstract: Polypeptides comprising functional mutants of an isoform of the human vascular endothelial growth factor A (VEGF-A) folded in a non-natural re-arrangement, where the second and fourth cysteine of the mutant's polypeptide chain is only forming intramolecular bridges, while the seventh and eight are only part of intermolecular bonds. The invention further comprises antigenic preparations containing at least one of these polypeptides, and the pharmaceutical compositions comprising such antigenic preparations and vaccine adjuvants. The antigenic preparations according to the invention are used in the manufacturing of a drug, for the treatment of diseases related to the increment of angiogenesis, inflammation, and immunosuppression, as well as for the restoration of the immune system.

Abstract: The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Cav1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

Abstract: Methods of operating a wind turbine (1) having a generator (10) and a power converter (60). The methods may comprise: determining a reduced first power setpoint (94) in response to an operational condition; reducing active power from a line-side converter (66) to an electrical grid (80) according to the reduced first power setpoint (94); determining a reduced power setpoint (92) for a machine-side converter (62); reducing a torque applied to the generator (10) by the machine-side converter (62) such that active power according to the reduced second power setpoint (92) is produced by the generator (10); and dissipating a power surplus in one or more resistive elements (68) as long as the second power setpoint is superior to the first power setpoint. Wind turbines configured for such methods are also provided.

Abstract: An imaging examination analysis method includes receiving a patient data set for a patient including measurements for a set of variables relating to a chronic medical condition, such as aortic stenosis (AS), obtained by an imaging examination of the patient. For one or more future time intervals, a likelihood is generated of a predetermined grade of the chronic medical condition (e.g. likelihood of severe AS grade) for the patient at the future time interval. The likelihood is generated using a classifier trained on training data sets for past patients. A follow-up imaging examination date recommendation is determined based on the likelihoods. An inconsistent measurement for the patient may be identified as a measurement whose value compared with a prior measurement for the same variable is consistent with an improvement in the chronic medical condition of the patient between the time of the prior measurement and a present time.

Abstract: A system and a method for identifying errors within a modular framework of a system comprising of a flight management system and an error reporting system. The modular components and correlating code modulars of the modular framework can be executed collectively or independently. Each modular component can be designed to incorporate independent modular updates or modifications.